• In hepatocellular carcinoma, SGC707 can inhibit the activity of PRMT3 and affect the methylation of LDHA by PRMT3; It can also block the enhancement of glycolysis induced by the overexpression of PRMT3. This evidence concerns the gene PRMT3 and hepatocellular carcinoma.